Erratum: Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: A randomized phase II trial by the prostate cancer clinical trials consortium (Investigational New Drugs DOI: 10.1007/s10637-010-9420-8)

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Bradley, DA; Daignault, S; Ryan, CJ; DiPaola, RS; Cooney, KA; Smith, DC; Small, E; Mathew, P; Gross, ME; Stein, MN; Chen, A; Pienta, KJ; Escara-Wilke, J; Doyle, G; Al-Hawary, M; Keller, ET; Hussain, M

Published Date

  • December 1, 2011

Published In

Volume / Issue

  • 29 / 6

Start / End Page

  • 1517 - 1518

Electronic International Standard Serial Number (EISSN)

  • 1573-0646

International Standard Serial Number (ISSN)

  • 0167-6997

Digital Object Identifier (DOI)

  • 10.1007/s10637-010-9502-7

Citation Source

  • Scopus